Recent advances in the identification of alpha1- and alpha2-adrenoceptor subtypes: therapeutic implications.
about
Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agentsSubtype selective alpha1-adrenoceptor antagonists for the treatment of benign prostatic hyperplasia.Novel role for alpha1-adrenergic receptor subtypes in lower urinary tract symptoms.The role of alpha1-adrenergic receptor subtypes in lower urinary tract symptoms.Safe and effective methylphenidate therapy in a pediatric patient with glaucoma.Clinical efficacy of an alpha1A/D-adrenoceptor blocker (naftopidil) on overactive bladder symptoms in patients with benign prostatic hyperplasia.
P2860
Recent advances in the identification of alpha1- and alpha2-adrenoceptor subtypes: therapeutic implications.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Recent advances in the identif ...... pes: therapeutic implications.
@en
Recent advances in the identif ...... pes: therapeutic implications.
@nl
type
label
Recent advances in the identif ...... pes: therapeutic implications.
@en
Recent advances in the identif ...... pes: therapeutic implications.
@nl
prefLabel
Recent advances in the identif ...... pes: therapeutic implications.
@en
Recent advances in the identif ...... pes: therapeutic implications.
@nl
P2860
P356
P1476
Recent advances in the identif ...... pes: therapeutic implications.
@en
P2093
Ruffolo RR Jr
P2860
P304
P356
10.1517/13543784.6.4.367
P407
P577
1997-04-01T00:00:00Z